Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 17 | 2022 | 2117 | 2.480 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2022 | 2211 | 1.730 |
Why?
|
Living Donors | 6 | 2019 | 618 | 1.120 |
Why?
|
End Stage Liver Disease | 3 | 2022 | 314 | 1.030 |
Why?
|
Hypertension, Renovascular | 2 | 2021 | 123 | 0.940 |
Why?
|
Aortic Diseases | 4 | 2020 | 741 | 0.870 |
Why?
|
HSP40 Heat-Shock Proteins | 2 | 2022 | 80 | 0.870 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2022 | 11 | 0.850 |
Why?
|
Liver Neoplasms | 6 | 2022 | 4249 | 0.820 |
Why?
|
Tissue Donors | 7 | 2022 | 2205 | 0.810 |
Why?
|
Aorta | 3 | 2020 | 2057 | 0.760 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 793 | 0.750 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 248 | 0.690 |
Why?
|
Hepatic Artery | 1 | 2019 | 242 | 0.650 |
Why?
|
Donor Selection | 2 | 2019 | 201 | 0.650 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2017 | 83 | 0.590 |
Why?
|
Tissue Expansion Devices | 4 | 2020 | 156 | 0.550 |
Why?
|
Graft Survival | 10 | 2020 | 3733 | 0.520 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4553 | 0.490 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.470 |
Why?
|
Vascular Surgical Procedures | 2 | 2020 | 1473 | 0.470 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 645 | 0.460 |
Why?
|
Viscera | 1 | 2014 | 139 | 0.460 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 270 | 0.440 |
Why?
|
Liver Regeneration | 1 | 2014 | 210 | 0.430 |
Why?
|
Up-Regulation | 1 | 2022 | 4211 | 0.430 |
Why?
|
Mesentery | 1 | 2013 | 205 | 0.420 |
Why?
|
Esophagus | 2 | 2016 | 1017 | 0.400 |
Why?
|
Tissue Expansion | 3 | 2020 | 162 | 0.390 |
Why?
|
Liver | 5 | 2020 | 7470 | 0.370 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2014 | 334 | 0.370 |
Why?
|
Kidney Transplantation | 5 | 2019 | 4246 | 0.360 |
Why?
|
Abdominal Injuries | 1 | 2013 | 352 | 0.360 |
Why?
|
Hospitals, Pediatric | 3 | 2020 | 1760 | 0.350 |
Why?
|
Intraoperative Care | 1 | 2013 | 766 | 0.340 |
Why?
|
Mesenteric Arteries | 2 | 2020 | 183 | 0.340 |
Why?
|
Body Weight | 1 | 2019 | 4664 | 0.330 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1158 | 0.330 |
Why?
|
Phosphoproteins | 2 | 2018 | 2440 | 0.320 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 1941 | 0.320 |
Why?
|
Organ Transplantation | 3 | 2017 | 1135 | 0.310 |
Why?
|
Biliary Tract | 1 | 2008 | 134 | 0.310 |
Why?
|
Thrombosis | 2 | 2019 | 2966 | 0.310 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2018 | 2915 | 0.290 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 794 | 0.290 |
Why?
|
Postoperative Complications | 6 | 2019 | 15244 | 0.280 |
Why?
|
Child, Preschool | 18 | 2020 | 40955 | 0.270 |
Why?
|
Infant | 17 | 2020 | 35070 | 0.260 |
Why?
|
Renal Artery | 2 | 2020 | 398 | 0.260 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1483 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8425 | 0.250 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5851 | 0.240 |
Why?
|
Child | 20 | 2022 | 77478 | 0.240 |
Why?
|
Decision Support Techniques | 1 | 2013 | 1952 | 0.220 |
Why?
|
Cell Proliferation | 3 | 2016 | 10472 | 0.210 |
Why?
|
Syndrome | 5 | 2020 | 3248 | 0.210 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2024 | 1421 | 0.210 |
Why?
|
Alagille Syndrome | 1 | 2021 | 35 | 0.200 |
Why?
|
Nephrectomy | 3 | 2019 | 1049 | 0.200 |
Why?
|
Kidney | 4 | 2021 | 7167 | 0.200 |
Why?
|
Pancreas Transplantation | 1 | 2022 | 188 | 0.200 |
Why?
|
Infant, Newborn | 7 | 2017 | 25575 | 0.180 |
Why?
|
Replantation | 1 | 2020 | 148 | 0.180 |
Why?
|
Iliac Artery | 1 | 2020 | 364 | 0.170 |
Why?
|
Adolescent | 17 | 2022 | 85649 | 0.170 |
Why?
|
Humans | 46 | 2024 | 742088 | 0.170 |
Why?
|
Biliary Atresia | 1 | 2019 | 72 | 0.160 |
Why?
|
Mitochondria | 2 | 2022 | 3520 | 0.160 |
Why?
|
Treatment Outcome | 15 | 2020 | 62966 | 0.160 |
Why?
|
Transplantation, Autologous | 2 | 2020 | 2123 | 0.160 |
Why?
|
Male | 31 | 2022 | 349538 | 0.160 |
Why?
|
Hyperoxaluria, Primary | 1 | 2017 | 22 | 0.160 |
Why?
|
Signal Transduction | 3 | 2018 | 23387 | 0.160 |
Why?
|
Oxalates | 1 | 2017 | 105 | 0.150 |
Why?
|
Constriction, Pathologic | 3 | 2021 | 1095 | 0.150 |
Why?
|
Herpesvirus 8, Human | 1 | 2019 | 258 | 0.150 |
Why?
|
Kidney Failure, Chronic | 3 | 2019 | 2536 | 0.150 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2016 | 37 | 0.140 |
Why?
|
Choledochostomy | 1 | 2016 | 15 | 0.140 |
Why?
|
Hepatoblastoma | 1 | 2017 | 87 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 196 | 0.140 |
Why?
|
Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.140 |
Why?
|
Umbilical Veins | 1 | 2017 | 433 | 0.140 |
Why?
|
Cyclin E | 1 | 2016 | 172 | 0.140 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 370 | 0.130 |
Why?
|
Inflammation | 3 | 2020 | 10578 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2020 | 933 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 290 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2020 | 388 | 0.130 |
Why?
|
Time Factors | 6 | 2020 | 40054 | 0.130 |
Why?
|
Female | 27 | 2021 | 379592 | 0.130 |
Why?
|
Retrospective Studies | 12 | 2020 | 77098 | 0.130 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1060 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 644 | 0.120 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
Models, Animal | 3 | 2016 | 2170 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2018 | 985 | 0.120 |
Why?
|
Biotransformation | 1 | 2013 | 168 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 409 | 0.110 |
Why?
|
Liver Circulation | 1 | 2013 | 163 | 0.110 |
Why?
|
Organ Size | 2 | 2019 | 2253 | 0.110 |
Why?
|
Learning Curve | 1 | 2015 | 200 | 0.110 |
Why?
|
Catheterization, Peripheral | 1 | 2017 | 344 | 0.110 |
Why?
|
Acid-Base Equilibrium | 1 | 2013 | 185 | 0.110 |
Why?
|
Renal Veins | 1 | 2013 | 108 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 340 | 0.110 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 101 | 0.110 |
Why?
|
HEK293 Cells | 1 | 2022 | 4200 | 0.110 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1161 | 0.110 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 346 | 0.110 |
Why?
|
Age Factors | 3 | 2020 | 18355 | 0.110 |
Why?
|
Length of Stay | 2 | 2016 | 6294 | 0.110 |
Why?
|
Oncogene Proteins | 1 | 2016 | 749 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2018 | 1973 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1469 | 0.100 |
Why?
|
Organogenesis | 1 | 2013 | 222 | 0.100 |
Why?
|
tau Proteins | 1 | 2021 | 1860 | 0.100 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4771 | 0.100 |
Why?
|
Hypertension | 4 | 2018 | 8455 | 0.100 |
Why?
|
Huntington Disease | 1 | 2018 | 1111 | 0.100 |
Why?
|
Neural Stem Cells | 1 | 2018 | 847 | 0.100 |
Why?
|
Boston | 4 | 2020 | 9305 | 0.100 |
Why?
|
Phosphorylation | 3 | 2021 | 8436 | 0.100 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1384 | 0.090 |
Why?
|
Hepatectomy | 1 | 2014 | 550 | 0.090 |
Why?
|
Duodenum | 1 | 2014 | 483 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 281 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2021 | 3081 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12242 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 437 | 0.090 |
Why?
|
Angioplasty | 1 | 2013 | 364 | 0.090 |
Why?
|
Risk Factors | 6 | 2019 | 72145 | 0.090 |
Why?
|
Vena Cava, Inferior | 1 | 2013 | 436 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 997 | 0.090 |
Why?
|
Hepatocytes | 1 | 2016 | 1209 | 0.090 |
Why?
|
Stomach | 1 | 2014 | 697 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2013 | 759 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.080 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2015 | 979 | 0.080 |
Why?
|
Creatinine | 1 | 2013 | 1916 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.080 |
Why?
|
Biliary Tract Diseases | 1 | 2008 | 160 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3444 | 0.080 |
Why?
|
Hippocampus | 1 | 2000 | 3661 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6534 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13403 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2968 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2041 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2000 | 3748 | 0.070 |
Why?
|
Pediatrics | 2 | 2020 | 3462 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 802 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3731 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2167 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9410 | 0.070 |
Why?
|
Models, Biological | 1 | 2022 | 9581 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4214 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8541 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1252 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 13029 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2195 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3276 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7721 | 0.060 |
Why?
|
Rats | 3 | 2016 | 24265 | 0.060 |
Why?
|
Databases, Factual | 2 | 2016 | 7716 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2566 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2043 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2016 | 3679 | 0.060 |
Why?
|
Health Care Costs | 1 | 2016 | 3203 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39004 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2015 | 3455 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3111 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9325 | 0.050 |
Why?
|
Gene Fusion | 1 | 2024 | 371 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12164 | 0.050 |
Why?
|
Clinical Competence | 1 | 2015 | 4681 | 0.040 |
Why?
|
Choline | 1 | 2000 | 487 | 0.040 |
Why?
|
Motor Neurons | 1 | 2024 | 851 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1092 | 0.040 |
Why?
|
Ganciclovir | 1 | 2019 | 259 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
Waiting Lists | 1 | 2022 | 692 | 0.040 |
Why?
|
Recurrence | 1 | 2009 | 8333 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29010 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 214 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2018 | 287 | 0.040 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2000 | 503 | 0.040 |
Why?
|
Portal Pressure | 1 | 2017 | 62 | 0.040 |
Why?
|
Pressure | 1 | 2020 | 1203 | 0.040 |
Why?
|
Albumins | 1 | 2019 | 568 | 0.040 |
Why?
|
Fluoxetine | 1 | 2000 | 749 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 431 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 643 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12071 | 0.030 |
Why?
|
Thrombelastography | 1 | 2017 | 163 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 365 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11001 | 0.030 |
Why?
|
Animals | 6 | 2022 | 168561 | 0.030 |
Why?
|
Tissue and Organ Procurement | 2 | 2013 | 890 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6756 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 458 | 0.030 |
Why?
|
Adult | 7 | 2019 | 213712 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1525 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8300 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 780 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2019 | 565 | 0.030 |
Why?
|
Drug Resistance | 1 | 2000 | 1608 | 0.030 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 406 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1407 | 0.030 |
Why?
|
Risk Assessment | 2 | 2019 | 23320 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1640 | 0.030 |
Why?
|
Ureterostomy | 1 | 2013 | 17 | 0.030 |
Why?
|
Functional Laterality | 1 | 2000 | 2290 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2026 | 0.030 |
Why?
|
Aged | 3 | 2021 | 162944 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4147 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2000 | 6030 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 656 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 213127 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2003 | 2633 | 0.030 |
Why?
|
Hyperplasia | 1 | 2016 | 1183 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3528 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2009 | 11470 | 0.030 |
Why?
|
Synapses | 1 | 2021 | 1724 | 0.030 |
Why?
|
Young Adult | 5 | 2019 | 56350 | 0.030 |
Why?
|
Paclitaxel | 1 | 2019 | 1707 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26343 | 0.020 |
Why?
|
Hemoglobins | 1 | 2017 | 1532 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2110 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1296 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3760 | 0.020 |
Why?
|
Liver Failure | 1 | 2012 | 240 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4646 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1864 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 40450 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2585 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 1333 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3612 | 0.020 |
Why?
|
Brain Death | 1 | 2012 | 347 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12344 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2699 | 0.020 |
Why?
|
Macrophages | 1 | 2003 | 5655 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3490 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2012 | 531 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9387 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3439 | 0.020 |
Why?
|
Intestine, Small | 1 | 2012 | 1243 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10248 | 0.020 |
Why?
|
Radiography | 1 | 2017 | 7010 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4393 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16665 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15530 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35342 | 0.020 |
Why?
|
United States | 3 | 2018 | 69693 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 2003 | 26 | 0.010 |
Why?
|
Angiostatins | 1 | 2003 | 67 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8925 | 0.010 |
Why?
|
Plasminogen | 1 | 2003 | 152 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13256 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8621 | 0.010 |
Why?
|
Depression | 1 | 2000 | 7733 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9679 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2003 | 475 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 694 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2003 | 617 | 0.010 |
Why?
|
Lymphokines | 1 | 2003 | 949 | 0.010 |
Why?
|
Inositol | 1 | 2000 | 216 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18006 | 0.010 |
Why?
|
Feedback | 1 | 2003 | 793 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
Creatine | 1 | 2000 | 421 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81045 | 0.010 |
Why?
|
Aspartic Acid | 1 | 2000 | 574 | 0.010 |
Why?
|
Cytosol | 1 | 2000 | 901 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2003 | 1438 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17400 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57683 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1675 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2593 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3502 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6452 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2003 | 5095 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20086 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2003 | 14554 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 21821 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2000 | 21719 | 0.000 |
Why?
|